Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables
- PMID: 34602502
- PMCID: PMC8842767
- DOI: 10.3233/JPD-212876
Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables
Abstract
Background: Parkinson's disease (PD) is a chronic, disabling neurodegenerative disorder.
Objective: To predict a future diagnosis of PD using questionnaires and simple non-invasive clinical tests.
Methods: Participants in the prospective Kuakini Honolulu-Asia Aging Study (HAAS) were evaluated biannually between 1995-2017 by PD experts using standard diagnostic criteria. Autopsies were sought on all deaths. We input simple clinical and risk factor variables into an ensemble-tree based machine learning algorithm and derived models to predict the probability of developing PD. We also investigated relationships of predictive models and neuropathologic features such as nigral neuron density.
Results: The study sample included 292 subjects, 25 of whom developed PD within 3 years and 41 by 5 years. 116 (46%) of 251 subjects not diagnosed with PD underwent autopsy. Light Gradient Boosting Machine modeling of 12 predictors correctly classified a high proportion of individuals who developed PD within 3 years (area under the curve (AUC) 0.82, 95%CI 0.76-0.89) or 5 years (AUC 0.77, 95%CI 0.71-0.84). A large proportion of controls who were misclassified as PD had Lewy pathology at autopsy, including 79%of those who died within 3 years. PD probability estimates correlated inversely with nigral neuron density and were strongest in autopsies conducted within 3 years of index date (r = -0.57, p < 0.01).
Conclusion: Machine learning can identify persons likely to develop PD during the prodromal period using questionnaires and simple non-invasive tests. Correlation with neuropathology suggests that true model accuracy may be considerably higher than estimates based solely on clinical diagnosis.
Keywords: Lewy body pathology; Parkinson’s disease; machine learning; neuron density.
Conflict of interest statement
The authors have no conflict of interest to report.
Figures




Similar articles
-
Gradient boosting for Parkinson's disease diagnosis from voice recordings.BMC Med Inform Decis Mak. 2020 Sep 15;20(1):228. doi: 10.1186/s12911-020-01250-7. BMC Med Inform Decis Mak. 2020. PMID: 32933493 Free PMC article.
-
Prediction of Future Parkinson Disease Using Plasma Proteins Combined With Clinical-Demographic Measures.Neurology. 2024 Aug 13;103(3):e209531. doi: 10.1212/WNL.0000000000209531. Epub 2024 Jul 8. Neurology. 2024. PMID: 38976826
-
Electrocardiographic changes predate Parkinson's disease onset.Sci Rep. 2020 Jul 9;10(1):11319. doi: 10.1038/s41598-020-68241-6. Sci Rep. 2020. PMID: 32647196 Free PMC article.
-
MDS research criteria for prodromal Parkinson's disease.Mov Disord. 2015 Oct;30(12):1600-11. doi: 10.1002/mds.26431. Mov Disord. 2015. PMID: 26474317 Review.
-
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.Mol Med. 2021 Sep 16;27(1):111. doi: 10.1186/s10020-021-00327-x. Mol Med. 2021. PMID: 34530732 Free PMC article. Review.
Cited by
-
Principles of Artificial Intellgence for Medicine.J Am Heart Assoc. 2024 Jun 18;13(12):e035815. doi: 10.1161/JAHA.124.035815. Epub 2024 Jun 15. J Am Heart Assoc. 2024. PMID: 38879454 Free PMC article. No abstract available.
-
Applications of Machine Learning to Diagnosis of Parkinson's Disease.Brain Sci. 2023 Nov 3;13(11):1546. doi: 10.3390/brainsci13111546. Brain Sci. 2023. PMID: 38002506 Free PMC article.
-
Artificial intelligence in neurology: opportunities, challenges, and policy implications.J Neurol. 2024 May;271(5):2258-2273. doi: 10.1007/s00415-024-12220-8. Epub 2024 Feb 17. J Neurol. 2024. PMID: 38367046 Free PMC article. Review.
-
Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram.Sci Rep. 2023 Jul 29;13(1):12290. doi: 10.1038/s41598-023-38782-7. Sci Rep. 2023. PMID: 37516770 Free PMC article.
-
Identifying prodromal symptoms at high specificity for Parkinson's disease.Front Aging Neurosci. 2023 Sep 22;15:1232387. doi: 10.3389/fnagi.2023.1232387. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37810617 Free PMC article.
References
-
- Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3, 17013. - PubMed
-
- Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32, 1264–1310. - PMC - PubMed
-
- Braak H, Braak E, Yilmazer D, Schultz C, de Vos RA, Jansen EN (1995) Nigral and extranigral pathology in Parkinson’s disease. J Neural Transm Suppl 46, 15–31. - PubMed